Hims & Hers Health, Inc. reports news about its consumer telehealth platform, which connects customers with providers and offers treatment options across areas such as sexual health, hair loss, skin care, mental health and weight loss. Company updates commonly cover prescription access, FDA-approved GLP-1 weight loss medications, platform memberships, subscriber benefits and health-and-wellness partner programs.
Recurring developments also include operating and financial results, conference participation, board and executive appointments, shareholder voting matters, governance updates and clinical or regulatory disclosures tied to products available through the Hims and Hers platform.
Hims & Hers (NYSE: HIMS) will report third quarter 2026 financial results after the market closes on November 9, 2026. The company will host a live conference call at 5:00 p.m. ET that day to discuss the results. A live audio webcast will be available at investors.hims.com and archived for one year.
Hims & Hers (HIMS) launched Hers in Australia, rebranding Juniper and completing the rollout of its platform in the country. Juniper, Eucalyptus' women's health platform, has served Australian patients since 2021. The rebrand follows Pilot's transition to Hims in August and the company's acquisition of Eucalyptus earlier this year.
Hers offers care spanning hair regrowth, menopause and perimenopause, and weight management. Services include access to medication, nutrition and fitness support, and a care team available 24/7. Weight-management patients also receive a digital companion grounded in more than 20 peer-reviewed studies focused on women's needs. Women may request a female practitioner across specialties. Gus Wood oversees Australia as general manager, while Dr. Matt Vickers serves as chief medical officer of Hims & Hers Australia.
Hims & Hers Health (HIMS) has appointed Jon Franklin as Chief Accounting Officer to oversee the company’s accounting organization. He reports to Chief Financial Officer Yemi Okupe and succeeds Irene Becklund, who announced her departure in July after seven years at the company. Becklund will serve as an advisor to support the transition.
Franklin is a Certified Public Accountant with two decades of technical accounting experience. He joins from Rivian, where he served as Vice President, Corporate Controller, responsible for technical accounting, corporate accounting and financial reporting. Previously, he spent more than 15 years in PwC’s Assurance division.
Hims & Hers Health (NYSE: HIMS) named Kultar Garcha and Matt Vickers to regional chief medical officer roles as it expands internationally. Garcha will serve as Chief Medical Officer of the UK and EMEA, covering Europe, the Middle East and Africa. Vickers will serve as Chief Medical Officer of Hims Australia. Both join the global medical leadership team led by Pat Carroll.
Garcha will oversee clinical quality, patient safety and prescribing standards across the UK and EMEA. He has over two decades of experience across public and private health systems, including almost 15 years as a practicing NHS general practitioner. Vickers will lead clinical strategy in Australia. He is a practicing general practitioner with more than a decade of family medical practice experience and has led health-tech efforts at Eucalyptus since 2019.
Hims & Hers Health (NYSE: HIMS) has entered the Australian market, its first expansion into the Asia-Pacific region, by rebranding Pilot, Eucalyptus’ men's health platform, under the Hims brand. This follows the earlier acquisition of Eucalyptus and makes Pilot the first Eucalyptus brand to transition.
According to Hims & Hers, Australia is a meaningful international growth opportunity, with the telehealth sector projected to reach USD $2.56 billion by 2034. The company expects Australia to help it achieve $1 billion in international annual revenue within three years. Existing Pilot customers retain their treatment plans and providers, now supported by Hims’ digital platform. Local operations are led by Tim Doyle as Senior Vice President of International, Gus Wood as General Manager of Australia, and Dr. Matt Vickers as Chief Medical Officer of Hims Australia.
Hims (NYSE:HIMS) is launching the Hims brand in Australia, following its earlier acquisition of Eucalyptus, by rebranding Eucalyptus' men's health platform Pilot. Effective immediately, Pilot becomes Hims, with patients retaining existing treatment plans and provider relationships while gaining access to Hims' personalised digital care platform.
According to Hims & Hers, Australian men will receive 24/7 access to a Care Team, expanded services for sexual health, weight loss, and hair loss, and new combined treatment options, including for premature ejaculation and cholesterol management. Local leadership is led by Tim Doyle and Gus Wood, with Dr. Matt Vickers serving as Chief Medical Officer for Hims Australia.
Hims & Hers (NYSE:HIMS) reported Q2 2026 revenue of $753.2 million, up 38% year-over-year, with subscribers reaching 2.89 million (+19%) and monthly revenue per average subscriber rising 21% to $92. Total revenue included $621.8 million from the U.S. (+16%) and $131.4 million from the rest of the world, up over 16-fold, supported by the June close of the Eucalyptus acquisition.
Gross margin declined to 64% from 76%, and the company recorded a net loss of $86.3 million versus prior-year net income of $42.5 million. Adjusted EBITDA was $60.3 million, down from $82.2 million. Hims & Hers raised full-year 2026 guidance to revenue of $3.1–$3.3 billion and Adjusted EBITDA of $275–$325 million, and guided Q3 2026 revenue to $880–$900 million with 9–11% Adjusted EBITDA margin.
Hims & Hers (NYSE:HIMS) announced a rebuilt Hers app offering what it describes as a first-of-its-kind, AI-native, doctor-led care experience, initially for Hers weight loss members. The app integrates providers, Care Teams, and AI into one continuous conversation to deliver personalized support, real-time progress monitoring, and timely clinical escalation.
According to the company, an optional new Hers smart scale, provided at no extra cost to weight loss members, syncs weight and GLP-1 progress data directly to the app. AI responses are guided by clinical protocols developed with weight-loss specialists, while providers retain decision-making authority. Hims & Hers plans to extend this AI-embedded model to the Hims app and additional categories over time.
Summary not available.
Hims & Hers (NYSE:HIMS) announced that Chief Accounting Officer Irene Becklund will leave the company after more than seven years, effective October 9, 2026. After her departure, she will serve as an advisor for several months to support the transition, while CFO Yemi Okupe assumes CAO responsibilities on an interim basis as the company searches for a permanent successor.
According to Hims & Hers, Becklund joined in 2019 as the first Controller and helped build the company’s financial reporting and public company infrastructure, contributing to its IPO, strategic acquisitions, and international expansion.